Skip to main content

Table 1 Overall survival analysis results of differentially expressed genes in early-stage basal-like/triple-negative breast cancer

From: Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer

Genes P value HR Low 95% CI High 95% CI
TROAP 0.025391 11.58053 1.352293 99.17133
CLDN7 0.028033 10.57329 1.289517 86.69483
GAS2L3 0.030351 10.3481 1.248294 85.78358
GAL 0.030437 10.5947 1.249694 89.82009
ZYG11A 0.03095 10.42861 1.239709 87.72707
UCK2 0.033021 10.17053 1.205618 85.79805
ANLN 0.033041 9.89309 1.20264 81.38202
PLPP1 0.034681 0.10048 0.011913 0.847494
PGAM5 0.036512 9.426576 1.151162 77.19189
GRHL2 0.038303 9.417034 1.128453 78.58594
FAM83D 0.038744 9.148677 1.121338 74.64144
HYLS1 0.039237 9.069905 1.114938 73.78271
SLC7A5 0.039748 9.121387 1.109184 75.00985
IL33 0.041652 0.112615 0.013774 0.920752
CENPE 0.042031 8.895662 1.081924 73.14081
YWHAZ 0.043559 8.711763 1.064576 71.29114
COA7 0.044402 8.712899 1.055671 71.91126
LIFR 0.04678 0.118868 0.014565 0.970122
ESPL1 0.047336 8.37144 1.025295 68.35204
PARPBP 0.048269 8.307202 1.016239 67.90686
TTC36 0.048538 0.120893 0.014815 0.986523
DOCK6 0.049538 8.280691 1.004277 68.27783
  1. HR hazard ratio, CI confidence interval, BC breast cancer